Are you looking for effective and well-tolerated veterinary treatment options to improve the quality of life for dogs with osteoarthritis (OA)?
While traditional therapies such as NSAIDs and opioids are standard, cannabidiol (CBD) has emerged as a compelling adjunctive or alternative option.
Backed by growing clinical research, CBD’s anti-inflammatory, analgesic, and neuroprotective properties make it a promising tool in the multimodal management of OA.
Here’s why CBD deserves consideration in your practice.
1. Proven Pain Relief and Anti-Inflammatory Effects
CBD interacts with the endocannabinoid system (ECS), which plays a crucial role in modulating pain and inflammation. By influencing cannabinoid receptors (CB1 and CB2), as well as TRPV1 (vanilloid) and PPAR receptors, CBD can help regulate pain perception and inflammatory responses.
Key Research Findings:
- A 2018 clinical study administered 2 mg/kg of CBD oil twice daily to dogs with OA and found a significant decrease in pain scores and an increase in activity levels, with no reported adverse effects. (Frontiers in Veterinary Science)
- A 2023 systematic review and meta-analysis of multiple studies concluded that CBD reduces OA-associated pain with minimal side effects, though further high-quality research is needed. (Frontiers in Veterinary Science)
- A 2020 pilot study on CBD-rich oil extract found that 30 out of 32 dogs with chronic OA pain improved in pain scores and mobility, and some were able to reduce or discontinue gabapentin.
2. Improved Safety Profile Compared to NSAIDs
While NSAIDs remain a mainstay in OA management, their long-term use is associated with adverse effects, particularly gastrointestinal ulcers, renal impairment, and hepatotoxicity.
CBD offers a safer alternative for chronic pain management, as studies indicate it has minimal side effects in dogs when properly dosed.
Key Considerations:
- CBD has been shown to be well-tolerated in both short-term and long-term studies, with the most common adverse effect being mild gastrointestinal upset.
- Unlike NSAIDs, CBD does not suppress prostaglandin synthesis, reducing the risk of gastric ulcers and renal complications.
- Some studies have reported increased alkaline phosphatase (ALP) levels, but these changes were asymptomatic.
3. Potential to Reduce Reliance on Opioids and Gabapentin
Many dogs with OA require adjunctive medications such as opioids or gabapentin for pain relief. However, these medications have drawbacks, including sedation, ataxia, and tolerance development.
- CBD may function as a gabapentin-sparing agent, allowing for dose reductions or discontinuation in some cases, as seen in the 2020 pilot study.
- The anti-neuropathic pain properties of CBD make it particularly relevant for managing chronic maladaptive pain in OA cases.
4. Supports Multimodal Pain Management
CBD should not necessarily replace traditional therapies, but can serve as an effective adjunct. Combining CBD with NSAIDs, physical therapy, weight management, and other interventions may optimise outcomes.
- A study on multimodal therapy for OA found that dogs receiving CBD alongside other treatments showed greater improvements in pain relief and mobility compared to NSAIDs alone.
- The potential for CBD to enhance endogenous cannabinoid signaling makes it a valuable addition to comprehensive OA management.
5. Regulatory and Clinical Considerations
Veterinarians should be mindful of product quality, dosing, and legal considerations when recommending CBD.
- Quality Control: Choose products with third-party lab testing to ensure consistency and purity.
- Dosing Guidelines: Studies suggest an effective dose range of 1-2 mg/kg twice daily, but individual titration may be necessary.
- Legal Status: CBD regulations vary by region; ensure compliance with local veterinary guidelines.
A Worthy Addition to OA Management
With a growing body of evidence supporting its efficacy and safety, CBD represents a viable option for canine OA pain management.
As more research emerges, it is likely that CBD will become a standard component of multimodal pain management strategies in veterinary medicine.
By considering CBD in your practice, you can offer pet owners a safe, effective, well-tolerated, and science-backed option to help their dogs live more comfortable, pain-free lives.
CBD Vets Australia: A Trusted Source for Veterinary CBD
CBD Vets Australia is leading the way in providing quality, veterinary-prescribed CBD to support dogs with OA and other chronic conditions.
As the first Australian company to supply legal, prescription-only CBD for pets, CBD Vets Australia is committed to supporting veterinarians by:
- Offering access to rigorously tested, compliant CBD products.
- Providing resources to help integrate CBD into your practice.
- Ensuring ongoing education to keep you informed about advancements and regulatory changes.
- Delivering ongoing support to assist you in confidently incorporating CBD into your veterinary care.
CBD for veterinarians has never been more accessible with the resources and products offered by CBD Vets Australia. Visit their website and register to prescribe HERE.
